Appropriate indications for venous duplex scanning based on D-dimer assay.

Lower extremity duplex scanning is frequently requested for diagnosing deep vein thrombosis (DVT). However, the high volume of scans raises concerns about unnecessary procedures. Prior research has shown that D-dimer assays can help rule out DVT in low-risk patients. No prior work had resolved how a rapid D-dimer test might function in specific clinical subgroups. This gap motivated the evaluation of a new assay, the Miniquant test, for its ability to avoid unnecessary imaging in patients with suspected DVT. Existing evidence suggested that D-dimer testing could reduce imaging in some populations. The uncertainty remained about whether this approach would work in patients with malignancy, postoperative status, or cellulitis. This study aimed to test the Miniquant assay in these subgroups. The goal was to determine if the test could safely exclude DVT and reduce the need for imaging.

The study aimed to evaluate the Miniquant D-dimer assay as a preselection tool for avoiding unnecessary lower extremity duplex scans in patients with suspected DVT. The specific problem addressed was the high rate of imaging requests and the potential for overuse in certain clinical subgroups. The motivation came from the need to reduce diagnostic costs and imaging utilization without compromising diagnostic accuracy. The researchers proposed that a rapid D-dimer test might help identify patients who do not require imaging. The study focused on subgroups with malignancy, postoperative status, and cellulitis. These groups were chosen because they may have elevated D-dimer levels unrelated to DVT. The goal was to determine if the Miniquant test could safely rule out DVT in these populations. The study sought to calculate sensitivity, specificity, and predictive values for the test in these subgroups.

The study involved 126 consecutive patients with suspected DVT who underwent clinical assessment and D-dimer testing with the Miniquant assay. All patients also received duplex scanning according to standard diagnostic criteria for DVT. The researchers categorized patients into subgroups based on malignancy status, postoperative status, and presence of cellulitis. They calculated sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) for the Miniquant test compared to duplex scanning results. The test was evaluated in each subgroup separately to assess its performance in different clinical contexts. The primary outcome was the NPV of the Miniquant test in ruling out DVT. The study used a prospective design with consecutive patient enrollment to ensure broad applicability. Data collection included both clinical and laboratory assessments to validate the test’s diagnostic utility.

The Miniquant D-dimer assay showed a high negative predictive value (NPV) in patients with suspected proximal DVT. The test was particularly useful in subgroups without malignancy or postoperative status. In patients with cellulitis, the Miniquant test also demonstrated a high NPV, suggesting it could safely exclude DVT in this group. Sensitivity and specificity values were consistent with prior studies using other D-dimer assays. The results indicated that the Miniquant test could help avoid unnecessary duplex scans in selected patient groups. The study found that the test had a high NPV but lower positive predictive value (PPV), meaning it was better at ruling out DVT than confirming it. The data suggest that the test is most effective when used as a preselection tool. The findings support the use of the Miniquant test in patients with specific risk factors to reduce imaging requests.

The authors concluded that the Miniquant D-dimer assay is a useful preselection tool for avoiding unnecessary lower extremity duplex scans in selected patient subgroups. The test demonstrated a high NPV in patients with suspected proximal DVT, including those with cellulitis and those without malignancy or postoperative status. The findings suggest that the test can safely rule out DVT in these groups. The study supports the use of the Miniquant test as a cost-saving and time-saving diagnostic aid. The authors proposed that the test may help reduce the number of unnecessary imaging procedures in specific clinical contexts. The results indicate that the test is most effective when used in conjunction with clinical assessment. The authors emphasized the importance of using the test in appropriate patient subgroups. They did not claim that the test can replace duplex scanning in all cases.